Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic Factors and Survival Outcomes in Resectable Thoracic Soft Tissue and Bone Sarcomas.

Cancers·2026
Same author

Machine Learning-Guided Survival Prediction and Treatment Sequencing in Advanced Soft Tissue Sarcoma Beyond Second-Line Therapy: A Retrospective Cohort Study.

Oncology and therapy·2026
Same author

Response to Letter to the Editor: Comments on "Surgery for Retroperitoneal Soft Tissue is Safe following Multimodal Treatment with Regional Hyperthermia".

Annals of surgical oncology·2026
Same author

Neoadjuvant chemotherapy for soft-tissue sarcoma of the extremities: A post-hoc Sarculator-based risk analysis of the EORTC 62961-ESHO 95 randomized trial.

Cancer·2026
Same author

Initial Clinical Experience with [<sup>177</sup>Lu]Lu-RTX-2358 Radiopharmaceutical Therapy Targeting Fibroblast Activation Protein: Biodistribution, Pharmacokinetics, and Dosimetry.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

Blinatumomab in Combined Immune Thrombocytopenia and Antiphospholipid Syndrome.

The New England journal of medicine·2026

Related Experiment Video

Updated: Jul 2, 2025

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

14.3K

[Current therapeutic standards in advanced soft tissue sarcomas].

Anton Burkhard-Meier1, Luc M Berclaz1, Dorit Di Gioia1

  • 1Medizinische Klinik und Poliklinik III, LMU Klinikum, München, Deutschland.

Deutsche Medizinische Wochenschrift (1946)
|February 27, 2024
PubMed
Summary

Soft tissue sarcomas are complex cancers requiring tailored treatments. Management ranges from surgery for localized tumors to chemotherapy and targeted therapies for advanced disease, improving patient outcomes.

More Related Videos

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

9.6K
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.1K

Related Experiment Videos

Last Updated: Jul 2, 2025

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

14.3K
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

9.6K
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.1K

Area of Science:

  • Oncology
  • Surgical Oncology
  • Medical Oncology

Context:

  • Soft tissue sarcomas represent a rare but complex group of adult malignancies, comprising less than 1% of all adult tumors.
  • The heterogeneity of over 80 subtypes presents significant diagnostic and therapeutic challenges.
  • Current treatment paradigms are evolving, necessitating a review of established and emerging strategies.

Purpose:

  • To provide an overview of the current standards of care for soft tissue sarcomas.
  • To highlight recent developments and novel therapeutic approaches in managing these complex tumors.
  • To discuss the multidisciplinary approach required for optimal patient management.

Summary:

  • Surgery is the primary treatment for localized soft tissue sarcomas.
  • Neoadjuvant chemotherapy and regional hyperthermia are options for high-risk localized disease to enhance tumor reduction and address micrometastases.
  • For metastatic disease, anthracycline-based chemotherapy is standard, with immune checkpoint inhibitors showing efficacy in specific subtypes like alveolar soft part sarcoma, and NTRK-inhibitor therapy being crucial for NTRK-fusion-positive tumors.

Impact:

  • This review aids oncologists and healthcare providers in navigating the complexities of soft tissue sarcoma treatment.
  • It emphasizes the importance of a multidisciplinary tumor board approach for optimal patient management.
  • The article highlights the potential of targeted therapies and immunotherapy to improve prognoses for specific soft tissue sarcoma subtypes.